Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30.82M | $1.32B | 12.15% | +614.4K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 13.73M | $588.0M | 5.41% | -187.1K | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 13.10M | $561.0M | 5.16% | -562.6K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12.09M | $518.0M | 4.76% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.26M | $482.0M | 4.44% | -- | 2026-03-31 |
| STATE STREET CORP | 10.30M | $441.0M | 4.06% | -192.9K | 2026-03-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 8.54M | $366.0M | 3.37% | +581.3K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 7.80M | $334.0M | 3.07% | +266.4K | 2026-03-31 |
| LSV ASSET MANAGEMENT | 7.75M | $332.0M | 3.05% | -217 | 2026-03-31 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4.83M | $207.0M | 1.91% | -442.6K | 2026-03-31 |
